Form 4 for GILD Gilead Sciences
Accepted 2025-06-11 00:00:00 ET · period of report 2025-06-10 · accession 0001127602-25-017339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-11 | 2025-06-10 | GILD | Wilfong Diane E. | CAO, Interim Corp Ctrl | M - OptEx | — | +920 | 46.0K | +2% | — |
| D | 2025-06-11 | 2025-06-10 | GILD | Wilfong Diane E. | CAO, Interim Corp Ctrl | F - Tax | $110.09 | -340 | 45.7K | -0.7% | -$37.4K |
| D | 2025-06-11 | 2025-06-10 | GILD | Wilfong Diane E. | CAO, Interim Corp Ctrl | M - OptEx | — | -920 | 8,785 | -9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-10 | M | A | 920 | — | 46,016 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2025-06-10 | F | D | 340 | $110.09 | 45,676 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-06-10 | M | D | 920 | — | 8,785 | D | — · — to — | 920 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |